C

CinCor Pharma, Inc.

23 employees

CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Pharmaceutical

Date founded

2018

Funding rounds raised

Total raised

$143M

from 12 investors over 12 rounds

C

CinCor Pharma, Inc. raised $143M on October 12, 2021

Investors: Sixty Degree Capital, Sofinnova Ventures, Russia technology fund, Lilly Asia Ventures, venBio Partners, Sofinnova Partners, General Atlantic, Perceptive Advisors, RTW Investments, LP and Omega Funds

C

CinCor Pharma, Inc. raised $50M on May 14, 2019

Investors: 5AM Ventures, Sofinnova Partners and Sofinnova Ventures, Russia technology fund

FAQ